Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans

In response to the Ebola virus (EBOV) crisis of 2013–2016, a recombinant vesicular stomatitis virus (VSV)–based EBOV vaccine was clinically tested (NCT02283099). A single-dose regimen of VSV-EBOV revealed a safe and immunogenic profile and demonstrated clinical efficacy. While EBOV-specific immune r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Infect Dis
Päätekijät: Poetsch, Joseph H, Dahlke, Christine, Zinser, Madeleine E, Kasonta, Rahel, Lunemann, Sebastian, Rechtien, Anne, Ly, My L, Stubbe, Hans C, Krähling, Verena, Biedenkopf, Nadine, Eickmann, Markus, Fehling, Sarah K, Olearo, Flaminia, Strecker, Thomas, Sharma, Piyush, Lang, Karl S, Lohse, Ansgar W, Schmiedel, Stefan, Becker, Stephan, Addo, Marylyn M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Major Articles and Brief Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350948/
https://ncbi.nlm.nih.gov/pubmed/30452666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy565
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia